Lv6
1710 积分 2020-08-09 加入
DHDH-mediated D-xylose metabolism induces immune evasion in triple-negative breast cancer
14天前
已完结
Siglec-9 acts as an immune-checkpoint molecule on macrophages in glioblastoma, restricting T-cell priming and immunotherapy response
15天前
已完结
Effects of Gonadotropin-Releasing Hormone Analogs on Ovarian Function Against Chemotherapy-Induced Gonadotoxic Effects in Premenopausal Women With Breast Cancer in China
1个月前
已完结
Navigating Treatment Pathways in Metastatic Hormone Receptor–Positive, HER2-Negative Breast Cancer: Optimizing Second-Line Endocrine and Targeted Therapies
2个月前
已完结
Adjuvant endocrine therapy in patients with estrogen receptor-low positive breast cancer: A prospective cohort study
2个月前
已完结
Abstract GS03-12: Phase III study of adjuvant ado-trastuzumab emtansine vs trastuzumab for residual invasive HER2-positive early breast cancer after neoadjuvant chemotherapy and HER2-targeted therapy: KATHERINE final IDFS and updated OS analysis
5个月前
已关闭
Ribociclib plus Endocrine Therapy in Early Breast Cancer
6个月前
已完结
Ribociclib Plus Endocrine Therapy in Premenopausal Women
6个月前
已完结
Ribociclib and endocrine therapy as adjuvant treatment in patients with HR+/HER2- early breast cancer: Primary results from the phase III NATALEE trial
6个月前
已完结
Abemaciclib plus endocrine therapy for hormone receptor-positive, HER2-negative, node-positive, high-risk early breast cancer (monarchE): results from a preplanned interim analysis of a randomised, open-label, phase 3 trial
6个月前
已完结
皖公网安备34019202002308
